Prenatal Lifestyle Interventions Improve Child Neurodevelopmental Outcomes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 25, 2023 -- Maternal structured lifestyle interventions during pregnancy based on a Mediterranean diet or mindfulness-based stress reduction (MBSR) improve child neurodevelopmental outcomes at age 2 years, according to a study published online on Aug. 22 in JAMA Network Open.
Francesca Crovetto, M.D., Ph.D., from the University of Barcelona in Spain, and colleagues examined whether structured interventions based on a Mediterranean diet or MBSR during pregnancy improve child neurodevelopment at age 2 years in a prespecified analysis of a parallel-group randomized clinical trial. A total of 1,221 singleton pregnancies with a high risk for developing newborns who were small for gestational age were randomly assigned to a Mediterranean diet intervention, including educational sessions and free provision of extra virgin olive oil and walnuts; an MBSR program adapted for pregnancy; or usual care per institutional protocols.
Neurodevelopment was assessed in 626 children at a mean age of 24.8 months. The researchers found that children in the Mediterranean diet group had higher scores in the cognitive and social-emotional domains than children from the usual care group (β, 5.02 and 5.15, respectively), while children from the stress reduction group had higher scores in the social-emotional domain (β, 4.75).
"These results need replication in further randomized clinical trials as well as assessment in additional patient populations," the authors write.
Several authors disclosed ties to the pharmaceutical, nutrition, and other industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization
FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...
Breakthrough Gene Therapy Enables Infant Born Deaf to Hear
FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...
Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure
FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.